证券代码：000881 证券简称：中广核技 中广核核技术发展股份有限公司投资者关系活动记录表 编号：2025-003 投资者关系活 动类别 特定对象调研 分析师会议 媒体采访 业绩说明会 新闻发布会 路演活动 现场参观 其他 外部参与人员 网络直播 上市公司参与 人员 董事长盛国福、独立董事王满、总会计师杨凌浩、副总经理马仕明 活动时间 2025 年 10 月 31 日 15:30-16:30 活动地点 会议链接：https://www.roadshowchina.cn/w/meet/p0Ow7V 记录 1．质子医疗设备什么时候可以交付使用？ 华西项目设备已完成出厂下线，客户现场一旦具备条件即可进入 安装阶段，预计年内无法完成验收。目前，公司还在积极拓展其他潜 在客户，现阶段密切跟踪的多个项目仍处于项目开发阶段。后续如有 重大进展，公司会根据相关规定的要求及时履行信息披露义务。 2．贵公司生产同位素国产替代咋样？市场开发方面有啥举措？ 国产替代方面，公司高度重视同位素国产替代战略，目前核心产 品锗镓发生器正处于从技术攻关到规模化供应的关键时期。同位素产 业具有技术壁垒高、审批流程严、产业链协同复杂的特性，从技 ...

Group 1: Project Status and Orders - The Huaxi Proton Medical Project's equipment has completed factory production, but installation cannot begin until site conditions are met, making year-end acceptance unlikely [2] - The company has not received new orders for proton therapy equipment in the last two years due to long preparation times for funding and construction, despite some hospitals obtaining configuration permits [2] - The company has completed technical breakthroughs and design for a miniaturized proton therapy system [2] Group 2: Product Development and Revenue - The isotope main equipment arrived at the production base in June 2025, with production planned for 2026 [3] - The company’s subsidiary is developing a special plastic product (Peek) for various industries, but it has not yet generated revenue [3] - The company’s revenue from the nuclear power sector is less than 10% [3] Group 3: Financial Performance and Strategies - The company aims to achieve profitability by reducing costs, enhancing strategic customer collaboration, and upgrading products based on market needs [3] - The company has faced significant losses for several years but is not currently at risk of being delisted according to stock exchange rules [4] - The company is focused on improving operational performance and enhancing investor relations to align intrinsic value with market value [4] Group 4: Corporate Governance and Future Plans - The company is not considering a private placement to increase shareholding ratios at this time [4] - The company is committed to completing its asset disposal work by the end of 2025 [4] - The company is actively embracing artificial intelligence to drive high-end, green, and intelligent transformation [5]

Valuation Improvement - 57 state-owned enterprises (SOEs) have officially released market value management systems, while 154 SOEs have drafted but not yet published their systems, and 30 SOEs have announced valuation enhancement plans[8] - The average price-to-book (PB) ratio of state-owned enterprises improved in the first half of 2025 compared to 2024, with the number of enterprises in the 5 to 8 PB ratio range doubling[8] - As of 2024, 30 SOEs had a PB ratio below 1, accounting for 7.4% of the total SOEs, all of which have released valuation enhancement plans[8] Market Capitalization - The number of small-cap SOEs (market cap below 5 billion yuan) decreased to 57, while the number of SOEs with a market cap between 30 billion and 100 billion yuan increased by 11, totaling 65[15] - Higher market capitalization helps SOEs better fulfill their roles in the economy, with market cap being a direct reflection of stock price changes[15] Institutional Investor Engagement - In Q1 2025, the proportion of institutional investors holding shares in state-owned enterprises increased by 3 percentage points year-on-year, primarily due to an increase in holdings by other institutions[19] - The introduction of policies promoting diversified equity structures aims to attract long-term institutional investors, with a focus on those holding more than 5% of shares[19] Economic Performance - From January to May 2025, the cumulative year-on-year growth of industrial added value for state-controlled enterprises was 6.3%, while fixed asset investment growth was 5.9%, outperforming the national average by 2.2 percentage points[26] - State-owned enterprises achieved total operating revenue of 32.8 trillion yuan and total profit of 1.7 trillion yuan in the same period, with a profit growth rate of -0.1%[26]